NVCR
Price:
$16.065
Market Cap:
$1.87B
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Industry
Medical - Devices
IPO Date
2015-10-02
Stock Exchange
NASDAQ
Ticker
NVCR
According to Novocure Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -10.50. This represents a change of -27.60% compared to the average of -14.50 of the last 4 quarters.
The mean historical PE Ratio of Novocure Ltd over the last ten years is -60.47. The current -10.50 PE Ratio has changed 1.64% with respect to the historical average. Over the past ten years (40 quarters), NVCR's PE Ratio was at its highest in in the September 2019 quarter at 934.75. The PE Ratio was at its lowest in in the June 2019 quarter at -1171.59.
Average
-60.47
Median
-23.98
Minimum
-1132.66
Maximum
865.20
Discovering the peaks and valleys of Novocure Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.23%
Maximum Annual PE Ratio = 865.20
Minimum Annual Increase = -176.39%
Minimum Annual PE Ratio = -1132.66
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -10.60 | -44.52% |
| 2024 | -19.10 | 149.50% |
| 2023 | -7.66 | -90.81% |
| 2022 | -83.35 | -37.83% |
| 2021 | -134.07 | -115.50% |
| 2020 | 865.20 | -176.39% |
| 2019 | -1132.66 | 2.23% |
| 2018 | -48.52 | 68.14% |
| 2017 | -28.86 | 466.11% |
| 2016 | -5.10 | -69.45% |
The current PE Ratio of Novocure Ltd (NVCR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12.45
5-year avg
-50.96
10-year avg
-60.47
Novocure Ltd’s PE Ratio is greater than Azenta, Inc. (-10.87), less than Kestra Medical Technologies, Ltd. (-10.28), greater than STAAR Surgical Company (-55.51), greater than BioLife Solutions, Inc. (-153.80), greater than Neogen Corporation (-348.55), less than Evotec SE (-3.18), less than Teladoc Health, Inc. (-7.01), greater than Establishment Labs Holdings Inc. (-63.48), greater than Pulse Biosciences, Inc. (-33.71), less than Upstream Bio, Inc. (-2.29),
| Company | PE Ratio | Market cap |
|---|---|---|
| -10.87 | $1.38B | |
| -10.28 | $1.46B | |
| -55.51 | $1.16B | |
| -153.80 | $1.62B | |
| -348.55 | $2.52B | |
| -3.18 | $702.66M | |
| -7.01 | $1.26B | |
| -63.48 | $2.76B | |
| -33.71 | $2.54B | |
| -2.29 | $361.89M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novocure Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novocure Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Novocure Ltd's PE Ratio?
How is the PE Ratio calculated for Novocure Ltd (NVCR)?
What is the highest PE Ratio for Novocure Ltd (NVCR)?
What is the 3-year average PE Ratio for Novocure Ltd (NVCR)?
What is the 5-year average PE Ratio for Novocure Ltd (NVCR)?
How does the current PE Ratio for Novocure Ltd (NVCR) compare to its historical average?